Search 

Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. 

Sapio Sciences' Seamless Informatics Platform provides Lab Management (LIMS), Electronic Lab Notebooks (ELN) and Scientific Data Management (SDMS) software. Manage your laboratories, notebooks, and scientific data from one centralized hub.

Lab Information Management System (LIMS): Effortless Workflow Tracking
Laboratories that want to track their lab processes effectively will benefit from our cutting-edge web-based Laboratory Information Management System (also known as a LIMS system). This software was built specifically to enable easy configuration of easy to use workflows to accurately track all your materials, instrument and other pertinent workflow data. Because it is web-based LIMS software, you can access it anywhere without help from your IT department.

Sapio supports quick creation of any workflow while also offering 6 specialized workflows on its LIMS system:

• Research LIMS
• NGS LIMS
• Clinical LIMS
• Histopathology LIMS
• Bioanalytical LIMS
• Stability LIMS

Electronic Lab Notebook (ELN): Evolving Lab Collaboration
Scientists can effortlessly build their experiments in an intuitive interface that allows them to track their experimental data, including supporting efficiency with its science-based widgets. Exemplar’s Electronic Lab Notebook Software breaks new ground in supporting effective collaboration, enabling numerous scientists to ideate and work on the same experiment at the same time while also supporting chat and discussions threads.

Exemplar Seamless: Driving Lab Efficiency
Exemplar Seamless is the informatics foundation of our ELN and LIMS software. A fully cloud-hosted platform, it breaks new ground in its breadth of functionality and ease of data and process configuration. Exemplar also includes best in class searching, data visualizations and analytics in a single integrated platform all reachable through its intuitive, responsive, web-based user interface.

Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.

Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).

Sareum is based in Cambridge, UK and listed on the AIM market of the London Stock Exchange, trading under the ticker SAR.

Scendea is a leading product development and regulatory consulting practice serving the pharmaceutical and biotechnology industry. We are adept at solving complex issues associated with medicinal product development and offer strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory. Our industry experience is demonstrable, having been involved in over 1,000 development programmes in the US and Europe over the last twenty years. As is our scientific excellence, with a team that includes ex-regulators, high-calibre academics and clinician scientists. Our technical regulatory expertise spans the entire product development spectrum from pre-clinical to marketing authorisation.

BioProduction by Sekisui offers contract development and manufacturing services for the biopharmaceutical industry.  Our facility in the UK has over 40 years of fermentation and purification experience with enzymes and proteins as our focus.  We offer expertise in bioprocess development, scale up and manufacturing of enzymes, plasmids, antibody fragments and other proteins.  We offer ISO 9001, ISO 13485 and GMP manufacturing quality standards for your custom production.  We are in the process of a $19M expansion of our GMP facility for drug substance manufacturing which will complete in 2023.

We create robust formulation development strategies tailored to the characteristics of each individual API. We complement the drug discovery process with clearly set-out costs for specific stages, totally transparent from the preclinical stage, formulation, dosage form development and optimisation.

Silence Therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells.

Our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. Using our enabling delivery systems, we have achieved an additional level of specificity by delivering our therapeutic RNA molecules exclusively to target cells. Silence’s proprietary RNA chemistries and delivery systems are designed to improve the stability of our molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases.

We are Simbec-Orion, who for almost five decades, have been providing clinical trial management services across a wide range of therapeutic indications and phases. The clinical research organisation with a flexible, specialist approach, we strive to become a trusted partner for our clients. Our passion as a CRO is rare diseases and oncology.

Sphere Fluidics is developing picodroplets and single cell analysis systems and services for therapeutic discovery.

Specialities
Biopharmaceutical, lab-on-a-chip, cells, antibodies, microfluidics, enzymes, cancer, biologics, biotechnology, pharmaceutical, life sciences, immunology, oncology, cell therapies, and stem cells

Sygnature Discovery is a leading independent integrated drug discovery and pre-clinical services CRO. Founded in 2004 and private equity-backed since 2017, we operate a fully-enabled research facilities in Nottingham and Alderley Park, UK housing over 500 staff (80% of our scientists have PhDs). Our experienced R&D scientists possess all the professional skills and know-how required to undertake the most demanding of drug discovery and/or pre-clinical development projects and drive them from target validation, through hit identification, hit-to-lead and lead optimization to development candidate. Sygnature collaborates with its partners via risk share and FTE-based collaborations.